Autopsy report · NCT04359953

Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

“difficulty in recruiting”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 16 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University Hospital, Strasbourg, France

Sponsor type

University, hospital or other

Conditions

COVID-19 Infection

Interventions

Hydroxychloroquine; Azithromycin; Telmisartan

Participants

16

Sites

1

Countries

France

Trials that died the same way

• Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle
  “difficulty recruiting” (99% match in meaning)
• Effectiveness Ankle-7 Orthosis VS HAFO Orthosis on Gait in Diplegic CPChildren
  “Difficulties in recruiting” (98% match in meaning)
• Mean Values of Oxidative Stress Parameters in Healthy Subjects
  “Problems with recruiting” (94% match in meaning)
• Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
  “Recruiting difficulties” (93% match in meaning)
• Fluid Management Based on Pleth Variability Index (PVI) Monitoring During High-risk Surgery
  “Problem with recruiting” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.